NG-52
CAS No. 212779-48-1
NG-52( Compound 52 )
Catalog No. M13385 CAS No. 212779-48-1
NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | In Stock |
|
| 5MG | 144 | In Stock |
|
| 10MG | 255 | In Stock |
|
| 25MG | 489 | In Stock |
|
| 50MG | 705 | In Stock |
|
| 100MG | 981 | In Stock |
|
| 500MG | 1971 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNG-52
-
NoteResearch use only, not for human use.
-
Brief DescriptionNG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.
-
DescriptionNG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase, Cdc28p (IC50 = 7 μM).
-
In VitroCell Proliferation Assay Cell Line:Glioma U87 and U251 cells Concentration:0 μM, 12.5 μM, 25 μM, 50 μM Incubation Time:6 days Result:Potently inhibited the proliferation of primary glioma cells.Western Blot Analysis Cell Line:Glioma U87 and U251 cells Concentration:0 μM, 12.5 μM, 25 μM, 50 μM Incubation Time:12 hours or 24 hours Result:Potently inhibited the proliferation of primary glioma cells.
-
In VivoAnimal Model:Female nu/nu mice (5-week-old) injected with glioma cells Dosage:50 mg/kg, 100 mg/kg, 150 mg/kg Administration:Oral administration; daily; for 13 daysResult:Dose-dependently suppressed the growth of glioma xenograft.
-
SynonymsCompound 52
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCdc28p
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number212779-48-1
-
Formula Weight346.81
-
Molecular FormulaC16H19ClN6O
-
Purity>98% (HPLC)
-
SolubilityDMSO: > 100mM
-
SMILESCC(C)N1C2=NC(NCCO)=NC(NC3=CC=CC(Cl)=C3)=C2N=C1
-
Chemical Name2-((6-((3-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)ethan-1-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.ray NS, et al. Science. 1998 Jul 24;281(5376):533-8.
molnova catalog
related products
-
JH-VIII-49
JH-VIII-49 is a potent and selective inhibitor of CDK8 with IC50 of 16 nM, also inhibits CDK19 (IC50=8 nM).
-
BAY-1251152
(±)-BAY-1251152 is a racemic mixture of BAY-1251152. BAY-1251152 is highly selective inhibitor of PTEF/CDK9.
-
SEL120-34A hydrochlo...
SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.
Cart
sales@molnova.com